Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Director departure
Inv. presentation
|
|
KIORA PHARMACEUTICALS INC (KPRX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/13/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 08/05/2022 |
SC 13G
| Lind Global Fund II LP reports a 9.9% stake in Kiora Pharmaceuticals, Inc. |
| 08/01/2022 |
SC 13G
| INTRACOASTAL CAPITAL, LLC reports a 10% stake in Kiora Pharmaceuticals, Inc. |
| 07/28/2022 |
SC 13G
| Lincoln Park Capital Fund, LLC reports a 10% stake in KIORA PHARMACEUTICALS, INC. |
| 08/20/2021 |
SC 13G
| Lind Global Fund II LP reports a 9.9% stake in EyeGate Pharmaceuticals, Inc. |
| 08/20/2021 |
SC 13G
| Empery Asset Management, LP reports a 6.9% stake in EyeGate Pharmaceuticals, Inc. |
| 08/19/2021 |
SC 13G
| BIGGER CAPITAL FUND L P reports a 6.3% stake in Eyegate Pharmaceuticals, Inc. |
| 08/18/2021 |
SC 13G
| INTRACOASTAL CAPITAL, LLC reports a 3.5% stake in EyeGate Pharmaceuticals, Inc. |
| 08/17/2021 |
SC 13G
| Lind Global Macro Fund LP reports a 9.9% stake in EyeGate Pharmaceuticals, Inc. |
| 08/13/2021 |
SC 13G
| ARMISTICE CAPITAL, LLC reports a 19.8% stake in EyeGate Pharmaceuticals, Inc. |
| 02/05/2020 |
SC 13G
| Hudson Bay Capital Management LP reports a 8.1% stake in EyeGate Pharmaceuticals, Inc. |
| 11/26/2018 |
SC 13G
| Lau Jonathan reports a 8.8% stake in Eyegate Pharmaceuticals, Inc. |
| 04/23/2018 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 06/19/2017 |
SC 13G
| ARMISTICE CAPITAL, LLC reports a 9.9% stake in Eyegate Pharmaceuticals, Inc. |
| 06/14/2017 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals |
|
|